vs
QuidelOrtho Corp（QDEL）与UFP INDUSTRIES INC（UFPI）财务数据对比。点击上方公司名可切换其他公司
UFP INDUSTRIES INC的季度营收约是QuidelOrtho Corp的1.9倍（$1.3B vs $699.9M），UFP INDUSTRIES INC净利率更高（3.0% vs -104.7%，领先107.7%），QuidelOrtho Corp同比增速更快（-3.7% vs -9.0%），UFP INDUSTRIES INC自由现金流更多（$82.7M vs $-94.7M），过去两年QuidelOrtho Corp的营收复合增速更高（-2.9% vs -9.9%）
奎德尔奥索公司是美国的诊断医疗产品制造商，旗下产品面向全球市场销售，深耕体外诊断领域，为医疗机构及相关用户提供专业的检测解决方案，助力全球医疗健康服务效率提升。
UFP工业是一家控股企业，业务覆盖零售、工业、建筑三大市场，总部位于美国密歇根州大急流城，1993年公开上市，旗下共有218家关联运营主体，面向零售、建筑、包装三大领域供应数万种产品。
QDEL vs UFPI — 直观对比
营收规模更大
UFPI
是对方的1.9倍
$699.9M
营收增速更快
QDEL
高出5.3%
-9.0%
净利率更高
UFPI
高出107.7%
-104.7%
自由现金流更多
UFPI
多$177.4M
$-94.7M
两年增速更快
QDEL
近两年复合增速
-9.9%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $699.9M | $1.3B |
| 净利润 | $-733.0M | $40.0M |
| 毛利率 | — | 16.3% |
| 营业利润率 | -100.7% | 4.4% |
| 净利率 | -104.7% | 3.0% |
| 营收同比 | -3.7% | -9.0% |
| 净利润同比 | -3583.4% | -41.3% |
| 每股收益（稀释后） | $-10.78 | $0.71 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收QDELUFPI
| Q4 25 | — | $1.3B | ||
| Q3 25 | $699.9M | $1.6B | ||
| Q2 25 | $613.9M | $1.8B | ||
| Q1 25 | $692.8M | $1.6B | ||
| Q4 24 | $707.8M | $1.5B | ||
| Q3 24 | $727.1M | $1.6B | ||
| Q2 24 | $637.0M | $1.9B | ||
| Q1 24 | $711.0M | $1.6B |
净利润QDELUFPI
| Q4 25 | — | $40.0M | ||
| Q3 25 | $-733.0M | $75.3M | ||
| Q2 25 | $-255.4M | $100.7M | ||
| Q1 25 | $-12.7M | $78.8M | ||
| Q4 24 | $-178.4M | $68.0M | ||
| Q3 24 | $-19.9M | $99.8M | ||
| Q2 24 | $-147.7M | $125.9M | ||
| Q1 24 | $-1.7B | $120.8M |
毛利率QDELUFPI
| Q4 25 | — | 16.3% | ||
| Q3 25 | — | 16.8% | ||
| Q2 25 | — | 17.0% | ||
| Q1 25 | — | 16.8% | ||
| Q4 24 | — | 16.4% | ||
| Q3 24 | — | 18.1% | ||
| Q2 24 | — | 19.1% | ||
| Q1 24 | — | 19.9% |
营业利润率QDELUFPI
| Q4 25 | — | 4.4% | ||
| Q3 25 | -100.7% | 5.7% | ||
| Q2 25 | -29.4% | 6.7% | ||
| Q1 25 | 4.7% | 5.8% | ||
| Q4 24 | -14.2% | 5.4% | ||
| Q3 24 | 2.1% | 7.3% | ||
| Q2 24 | -18.4% | 8.4% | ||
| Q1 24 | -247.3% | 8.2% |
净利率QDELUFPI
| Q4 25 | — | 3.0% | ||
| Q3 25 | -104.7% | 4.8% | ||
| Q2 25 | -41.6% | 5.5% | ||
| Q1 25 | -1.8% | 4.9% | ||
| Q4 24 | -25.2% | 4.7% | ||
| Q3 24 | -2.7% | 6.1% | ||
| Q2 24 | -23.2% | 6.6% | ||
| Q1 24 | -239.9% | 7.4% |
每股收益（稀释后）QDELUFPI
| Q4 25 | — | $0.71 | ||
| Q3 25 | $-10.78 | $1.29 | ||
| Q2 25 | $-3.77 | $1.70 | ||
| Q1 25 | $-0.19 | $1.30 | ||
| Q4 24 | $-2.54 | $1.12 | ||
| Q3 24 | $-0.30 | $1.64 | ||
| Q2 24 | $-2.20 | $2.05 | ||
| Q1 24 | $-25.50 | $1.96 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $98.1M | $948.6M |
| 总债务越低越好 | $2.5B | $229.8M |
| 股东权益账面价值 | $2.0B | $3.1B |
| 总资产 | $5.7B | $4.0B |
| 负债/权益比越低杠杆越低 | 1.23× | 0.08× |
8季度趋势，按日历期对齐
现金及短期投资QDELUFPI
| Q4 25 | — | $948.6M | ||
| Q3 25 | $98.1M | $1.0B | ||
| Q2 25 | $151.7M | $874.0M | ||
| Q1 25 | $127.1M | $934.3M | ||
| Q4 24 | $98.3M | $1.2B | ||
| Q3 24 | $143.7M | $1.2B | ||
| Q2 24 | $107.0M | $1.1B | ||
| Q1 24 | $78.5M | $1.0B |
总债务QDELUFPI
| Q4 25 | — | $229.8M | ||
| Q3 25 | $2.5B | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $2.1B | $234.0M | ||
| Q3 24 | $2.2B | — | ||
| Q2 24 | $2.2B | — | ||
| Q1 24 | $2.2B | — |
股东权益QDELUFPI
| Q4 25 | — | $3.1B | ||
| Q3 25 | $2.0B | $3.2B | ||
| Q2 25 | $2.8B | $3.1B | ||
| Q1 25 | $3.0B | $3.2B | ||
| Q4 24 | $3.0B | $3.2B | ||
| Q3 24 | $3.2B | $3.2B | ||
| Q2 24 | $3.2B | $3.1B | ||
| Q1 24 | $3.3B | $3.1B |
总资产QDELUFPI
| Q4 25 | — | $4.0B | ||
| Q3 25 | $5.7B | $4.1B | ||
| Q2 25 | $6.4B | $4.1B | ||
| Q1 25 | $6.5B | $4.2B | ||
| Q4 24 | $6.4B | $4.2B | ||
| Q3 24 | $6.8B | $4.2B | ||
| Q2 24 | $6.7B | $4.1B | ||
| Q1 24 | $6.7B | $4.1B |
负债/权益比QDELUFPI
| Q4 25 | — | 0.08× | ||
| Q3 25 | 1.23× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.70× | — | ||
| Q4 24 | 0.72× | 0.07× | ||
| Q3 24 | 0.68× | — | ||
| Q2 24 | 0.70× | — | ||
| Q1 24 | 0.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-45.5M | $146.6M |
| 自由现金流经营现金流 - 资本支出 | $-94.7M | $82.7M |
| 自由现金流率自由现金流/营收 | -13.5% | 6.2% |
| 资本支出强度资本支出/营收 | 7.0% | 4.8% |
| 现金转化率经营现金流/净利润 | — | 3.67× |
| 过去12个月自由现金流最近4个季度 | $-153.1M | $276.4M |
8季度趋势，按日历期对齐
经营现金流QDELUFPI
| Q4 25 | — | $146.6M | ||
| Q3 25 | $-45.5M | $286.0M | ||
| Q2 25 | $-46.8M | $221.9M | ||
| Q1 25 | $65.6M | $-108.8M | ||
| Q4 24 | $63.7M | $144.9M | ||
| Q3 24 | $117.9M | $258.6M | ||
| Q2 24 | $-97.9M | $255.9M | ||
| Q1 24 | $-700.0K | $-16.8M |
自由现金流QDELUFPI
| Q4 25 | — | $82.7M | ||
| Q3 25 | $-94.7M | $210.2M | ||
| Q2 25 | $-84.3M | $159.5M | ||
| Q1 25 | $9.4M | $-176.1M | ||
| Q4 24 | $16.5M | $78.1M | ||
| Q3 24 | $71.4M | $199.7M | ||
| Q2 24 | $-133.2M | $198.4M | ||
| Q1 24 | $-66.8M | $-65.9M |
自由现金流率QDELUFPI
| Q4 25 | — | 6.2% | ||
| Q3 25 | -13.5% | 13.5% | ||
| Q2 25 | -13.7% | 8.7% | ||
| Q1 25 | 1.4% | -11.0% | ||
| Q4 24 | 2.3% | 5.3% | ||
| Q3 24 | 9.8% | 12.1% | ||
| Q2 24 | -20.9% | 10.4% | ||
| Q1 24 | -9.4% | -4.0% |
资本支出强度QDELUFPI
| Q4 25 | — | 4.8% | ||
| Q3 25 | 7.0% | 4.9% | ||
| Q2 25 | 6.1% | 3.4% | ||
| Q1 25 | 8.1% | 4.2% | ||
| Q4 24 | 6.7% | 4.6% | ||
| Q3 24 | 6.4% | 3.6% | ||
| Q2 24 | 5.5% | 3.0% | ||
| Q1 24 | 9.3% | 3.0% |
现金转化率QDELUFPI
| Q4 25 | — | 3.67× | ||
| Q3 25 | — | 3.80× | ||
| Q2 25 | — | 2.20× | ||
| Q1 25 | — | -1.38× | ||
| Q4 24 | — | 2.13× | ||
| Q3 24 | — | 2.59× | ||
| Q2 24 | — | 2.03× | ||
| Q1 24 | — | -0.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
QDEL
| Labs | $373.8M | 53% |
| Point Of Care | $164.6M | 24% |
| Immunohematology | $142.0M | 20% |
| Donor Screening | $14.7M | 2% |
| Molecular Diagnostics | $4.8M | 1% |
| Collaborative Arrangement Transaction With Party To Collaborative Arrangement | $2.1M | 0% |
UFPI
| Retail Segment | $444.0M | 33% |
| Structural Packaging | $230.2M | 17% |
| Factory Built | $189.7M | 14% |
| Site Built | $152.7M | 11% |
| Palletone Inc | $119.2M | 9% |
| Deckorators | $55.2M | 4% |
| Commercial | $53.2M | 4% |
| Concrete Forming | $44.2M | 3% |
| Transferred Over Time | $29.6M | 2% |
| Protective Packaging | $20.7M | 2% |
